Quantum Discovery
Quantum Discovery Labs is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services, and pursue our own in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and anti-cancer efficacy.
Quantum@linkedin.com
Contacts: office@q-pharm.com or comment any post on the site. You are welcome!
Quantum on Google+
Latest Headlines
-
![A key issue in the development of novel HIV drugs is their ability to inhibit the replication of genetically diverse isolates, especially those isolates from the most globally prevalent subtypes, [...]](http://q-pharm.com/wp-content/uploads/2011/06/variousvirustypes.png "New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1")
New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1
Posted on June 21, 2011 | No CommentsA key issue in the development of novel HIV drugs is their ability to inhibit the replication of genetically diverse isolates, especially those isolates from the most globally prevalent subtypes, [...] -
![We have recently reported a discovery of novel potent inhibitors of influenza M1 matrix protein. The matrix protein structurally forms the protein envelope and has no close human analogues. That’s [...]](http://q-pharm.com/wp-content/uploads/2011/04/chart_1.png "Influenza matrix M1 protein inhibitors show promising in-vivo efficacy")
Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
Posted on April 10, 2011 | 1 CommentWe have recently reported a discovery of novel potent inhibitors of influenza M1 matrix protein. The matrix protein structurally forms the protein envelope and has no close human analogues. That’s [...] -
![QP42 is the lead compound in its class, a novel anti-TB compound with a novel mechanism of action. The molecule is being developed by Quantum and is currently in preclinical [...]](http://q-pharm.com/wp-content/uploads/2010/12/chart_7.png "QP42 in-vitro efficacy summary (MDR, XDR strains, other drugs/drug candidates)")
QP42 in-vitro efficacy summary (MDR, XDR strains, other drugs/drug candidates)
Posted on December 21, 2010 | No CommentsQP42 is the lead compound in its class, a novel anti-TB compound with a novel mechanism of action. The molecule is being developed by Quantum and is currently in preclinical [...] -
![Quantum Free energy calculation software in combination with the docking tools and clustering tools to “zip” the amount of work required to screen the large libraries of the available chemical [...]](http://q-pharm.com/wp-content/uploads/2010/07/influenza.png "Beefing up the pipeline: new leads against influenza virus identified")
Beefing up the pipeline: new leads against influenza virus identified
Posted on September 20, 2010 | No CommentsQuantum Free energy calculation software in combination with the docking tools and clustering tools to “zip” the amount of work required to screen the large libraries of the available chemical [...] -
![Increasing numbers of target protein structures available for computational studies makes the structure-based screening paradigm more attractive for initial hit indentification. We have developed a novel in silico screening methodology [...]](http://q-pharm.com/wp-content/themes/arras-theme/images/thumbnail.png "Application of a novel in silico high throughput screen to identify selective inhibitors for protein–protein interactions")
Application of a novel in silico high throughput screen to identify selective inhibitors for protein–protein interactions
Posted on August 5, 2010 | No CommentsIncreasing numbers of target protein structures available for computational studies makes the structure-based screening paradigm more attractive for initial hit indentification. We have developed a novel in silico screening methodology [...]